
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+11
CytoReason is a tech company transforming biopharmas decision-making from trial and error to data-driven using an AI Platform of computational disease models. With its extensive database of public and proprietary data, the company maps human diseases tissue by tissue and cell by cell. Researchers of all levels rely on CytoReasons technology to make data-driven decisions across the drug development life cycle. Scientists can identify potential targets, prioritize indications, and stratify patient populations. Program leaders can compare drugs across multiple diseases or multiple drugs within a single disease. C-level executives can gain valuable tools to manage and optimize entire drug portfolios...
Bioinformatics,machine learning,data science,computational drug discovery,target discovery,indication prioritisation,patient stratification,biomarker discovery,immune system,cancer immunotherapy,combinations,indications,inflammatory bowel disease,atopic dermatitis,cells,and artificial intelligence
Cytoreason operates in the Biotechnology research industry.
Cytoreason's revenue is 11m - 100m
Cytoreason has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.